UPDATE 1-Allergan-bidder Valeant cuts 2014 outlook

July 31 (Reuters) - Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, cut its full-year profit and revenue forecasts to reflect the sale of its rights to several skincare products.